{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:09:29Z","timestamp":1780304969103,"version":"3.54.0"},"reference-count":25,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T00:00:00Z","timestamp":1780185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background\/Objectives: The optimal surgical margin width after breast-conserving surgery (BCS) for pure ductal carcinoma in situ (DCIS) remains controversial; although current guidelines consider a surgical margin of \u22652 mm sufficient, the clinical safety of narrower margins is unclear. This study aimed to evaluate the association between surgical margin width and ipsilateral breast tumor recurrence (IBTR), with a focus on the 1 mm threshold. Materials and Methods: In this retrospective single-center cohort study, 107 patients with pure DCIS treated with BCS followed by adjuvant radiotherapy (RT) between 1 January 2009 and 1 January 2025 were analyzed. Final surgical margins were categorized as &lt;1 mm, 1\u20132 mm, and \u22652 mm. The primary endpoint was IBTR. Kaplan\u2013Meier analysis was performed. Results: The median age of the study population was 52 years (IQR: 46\u201361). High-grade DCIS was present in 48 patients (44.9%), comedo necrosis in 68 (63.6%), and estrogen receptor positivity in 87 (81.3%). Overall, 10 patients (9.3%) underwent re-excision for margin widening. Final surgical margin widths were &lt;1 mm in 36 patients (34%), 1\u20132 mm in 18 (17%), and \u22652 mm in 53 (49%). IBTR occurred in seven patients (6.5%) during a median follow-up of 48 months (range, 12\u2013217 months), with a median time to recurrence of 33 months. Kaplan\u2013Meier analysis showed no significant difference in recurrence-free survival according to a 2 mm margin threshold, whereas margins &lt; 1 mm were associated with significantly worse outcomes (p = 0.002). Conclusions: Margins &lt; 1 mm were associated with increased IBTR risk, whereas margins &lt; 2 mm did not appear to confer uniform risk. These findings suggest that margin widths between 1 and 2 mm may represent a heterogeneous group, and clinical decision-making in this range should be individualized. However, further studies are needed to validate these outcomes.<\/jats:p>","DOI":"10.3390\/medicina62061061","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T08:09:16Z","timestamp":1780301356000},"page":"1061","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimal Surgical Margin After Breast-Conserving Surgery in Pure Ductal Carcinoma in Situ: Is a 1 mm Margin Sufficient? A Retrospective Single-Center Cohort Study"],"prefix":"10.3390","volume":"62","author":[{"given":"Ufuk","family":"Karabacak","sequence":"first","affiliation":[{"name":"Department of General Surgery, Faculty of Medicine, Ondokuz May\u0131s University, Samsun 55200, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Derebey","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Faculty of Medicine, Ondokuz May\u0131s University, Samsun 55200, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail Alper","family":"Tarim","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Faculty of Medicine, Ondokuz May\u0131s University, Samsun 55200, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saim Savas","family":"Yuruker","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Faculty of Medicine, Ondokuz May\u0131s University, Samsun 55200, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahadir Bulent","family":"Gungor","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Faculty of Medicine, Ondokuz May\u0131s University, Samsun 55200, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayfer","family":"Kamali Polat","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Faculty of Medicine, Ondokuz May\u0131s University, Samsun 55200, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41392-024-01779-3","article-title":"Progression from ductal carcinoma in situ to invasive breast cancer: Molecular features and clinical significance","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Oses, G., Mension, E., Pumarola, C., Castillo, H., Francesc, L., Torras, I., Cebrecos, I., Caparr\u00f3s, X., Ganau, S., and Ubeda, B. (2023). Analysis of Local Recurrence Risk in Ductal Carcinoma In Situ and External Validation of the Memorial Sloan Kettering Cancer Center Nomogram. Cancers, 15.","DOI":"10.3390\/cancers15082392"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamasurg.2017.2181","article-title":"Factors Associated with Underestimation of Invasive Cancer in Patients with Ductal Carcinoma In Situ: Precautions for Active Surveillance","volume":"152","author":"Bonev","year":"2017","journal-title":"JAMA Surg."},{"key":"ref_4","unstructured":"Gandhi, A., Cunnick, G., Gibson, E., Hubbard, T., Leff, D., Pinder, S.E., Rigby, K., Skervin, A., Tang, S., and Cox, K. (2024). Recommendations for the Management of Radial Surgical Margins in Patients Undergoing Breast Conserving Surgery for Ductal Carcinoma In Situ (DCIS), Association of Breast Surgery."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.annonc.2023.11.016","article-title":"Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"35","author":"Loibl","year":"2024","journal-title":"Ann. Oncol."},{"key":"ref_6","unstructured":"American Society of Breast Surgeons (2024). Breast Conservation Surgery Margins, American Society of Breast Surgeons."},{"key":"ref_7","unstructured":"National Comprehensive Cancer Network (2026). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Breast Cancer: Ductal Carcinoma In Situ (DCIS), National Comprehensive Cancer Network."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Niwi\u0144ska, A., and Kunkiel, M. (2022). Type of Recurrence, Cause of Death and Second Neoplasms among 737 Patients with Ductal Carcinoma In Situ of the Breast\u201415-Year Follow-Up. Cancers, 14.","DOI":"10.3390\/cancers14030669"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/SLA.0000000000002439","article-title":"Ductal Carcinoma In Situ and Margins <2 mm: Contemporary Outcomes with Breast Conservation","volume":"269","author":"Tadros","year":"2019","journal-title":"Ann. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10549-021-06129-3","article-title":"Patterns of invasive recurrence among patients originally treated for ductal carcinoma in situ by breast-conserving surgery versus mastectomy","volume":"186","author":"Pawloski","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3348\/kjr.2024.0268","article-title":"A Nomogram Using Imaging Features to Predict Ipsilateral Breast Tumor Recurrence After Breast-Conserving Surgery for Ductal Carcinoma In Situ","volume":"25","author":"Choi","year":"2024","journal-title":"Korean J. Radiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/SLA.0000000000001454","article-title":"Relationship Between Margin Width and Recurrence of Ductal Carcinoma In Situ: Analysis of 2996 Women Treated with Breast-conserving Surgery for 30 Years","volume":"262","author":"Subhedar","year":"2015","journal-title":"Ann. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1245\/s10434-016-5446-2","article-title":"The Association of Surgical Margins and Local Recurrence in Women with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy: A Meta-Analysis","volume":"23","author":"Marinovich","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.ejso.2017.08.003","article-title":"Margin width and local recurrence after breast conserving surgery for ductal carcinoma in situ","volume":"43","author":"Ekatah","year":"2017","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_15","first-page":"e1502","article-title":"Impact of consensus guidelines for breast-conserving surgery in patients with ductal carcinoma in situ","volume":"5","author":"Tremelling","year":"2022","journal-title":"Cancer Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1245\/s10434-020-08610-7","article-title":"Adoption of SSO-ASTRO Margin Guidelines for Ductal Carcinoma in Situ: What Is the Impact on Use of Additional Surgery?","volume":"28","author":"Mamtani","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"ref_17","first-page":"100793","article-title":"Surgical margin and local recurrence of ductal carcinoma in situ","volume":"39","author":"Co","year":"2024","journal-title":"Cancer Treat. Res. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.prro.2016.06.011","article-title":"Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma in Situ","volume":"6","author":"Morrow","year":"2016","journal-title":"Pr. Radiat. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.1245\/s10434-021-10120-z","article-title":"Effect of the Ductal Carcinoma In Situ Margin Consensus Guideline Implementation on Re-Excision Rates, Satisfaction, and Cost","volume":"28","author":"Bhutiani","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"116401","DOI":"10.1016\/j.amjsurg.2025.116401","article-title":"Quality of life and decision satisfaction after re-excision in breast cancer surgery","volume":"249","author":"Beight","year":"2025","journal-title":"Am. J. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/jamasurg.2017.2661","article-title":"Beyond the Margins-Economic Costs and Complications Associated with Repeated Breast-Conserving Surgeries","volume":"152","author":"Metcalfe","year":"2017","journal-title":"JAMA Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12032-022-01876-9","article-title":"The clinical significance of HER2 expression in DCIS","volume":"40","author":"Akrida","year":"2022","journal-title":"Med. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"zrac022","DOI":"10.1093\/bjsopen\/zrac022","article-title":"Sentinel lymph node biopsy in patients with ductal carcinoma in situ: Systematic review and meta-analysis","volume":"6","author":"Davey","year":"2022","journal-title":"BJS Open"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Akrida, I., Michalopoulos, N.V., Lagadinou, M., Papadoliopoulou, M., Maroulis, I., and Mulita, F. (2023). An Updated Review on the Emerging Role of Indocyanine Green (ICG) as a Sentinel Lymph Node Tracer in Breast Cancer. Cancers, 15.","DOI":"10.3390\/cancers15245755"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Papadoliopoulou, M., Matiatou, M., Koutsoumpos, S., Mulita, F., Giannios, P., Margaris, I., Moutzouris, K., Arkadopoulos, N., and Michalopoulos, N.V. (2023). Optical Imaging in Human Lymph Node Specimens for Detecting Breast Cancer Metastases: A Review. Cancers, 15.","DOI":"10.3390\/cancers15225438"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/6\/1061\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T08:48:07Z","timestamp":1780303687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/6\/1061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,31]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["medicina62061061"],"URL":"https:\/\/doi.org\/10.3390\/medicina62061061","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,31]]}}}